
Natural Capsules (NATCAPSUQ) Share Price Near 52-Week Low as Stock Slips 2.97%
Updated: 19 Nov 2026 • 3:28 pm
Posted by:

Natural Capsules Share Price is Rs 134, down 2.97%, and trading close to its 52-week low with market capitalisation of Rs 152.28 crore. Natural Capsules Share Price Today reflects weak intraday price action, while Univest data shows no company-specific catalyst behind the move. The latest Natural Capsules Stock News therefore centres on price behaviour, valuation, and the fact that the share is still below its 50-day and 200-day moving averages. Investors tracking Natural Capsules Share Price News are likely watching whether the move remains part of broader selling pressure or simply a short-term drift within a small-cap healthcare name.
Natural Capsules Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 134 |
| Previous Close | Rs 138.1 |
| Today's Move | Rs -4.1 (-2.97%) |
| Open | Rs 138.1 |
| High | Rs 138.1 |
| Low | Rs 134 |
| Market Capitalisation | Rs 152.28 crore |
Natural Capsules Ltd. (NATCAPSUQ) traded at Rs 134 versus the previous close of Rs 138.1, a fall of 2.97%. The stock opened at Rs 138.1, reached a high of Rs 138.1, touched a low of Rs 134.
Natural Capsules Share Price Today opened at Rs 138.1, matched the previous close of Rs 138.1, and then moved lower to a day low of Rs 134. It touched a high of Rs 138.1 and last traded at Rs 134, leaving the stock down Rs 4.1 or 2.97% on the day. The move keeps Natural Capsules Share Price near its 52-week low and places it within a narrow intraday range, which is often how weak price action appears when support is under pressure. Market capitalisation stands at Rs 152.28 crore, placing the company in the micro-cap to small-cap bracket. For Natural Capsules Share Price Today, the key point is simple: the stock is trading below the opening level, below the previous close and close to its yearly low, so the market is still treating it with caution. That sets up the technical picture that follows for Natural Capsules Share Price.
Natural Capsules Ltd. (NATCAPSUQ) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 152.28 crore |
| P/E Ratio | 20.59x |
| P/B Ratio | 0.66x |
| ROE | -10.89% |
| ROCE | -4.85% |
| EPS | Rs -14.97 |
| Book Value Per Share | Rs 208.8 |
| Dividend Yield | 0% |
Natural Capsules Ltd. (NATCAPSUQ) fundamental metrics show P/E 20.59x, P/B 0.66x, ROE -10.89%, ROCE -4.85%. These figures provide context only and are not a buy or sell signal.
Natural Capsules Ltd. has a market capitalisation of Rs 152.28 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 20.59x, P/B at 0.66x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -10.89% and ROCE of -4.85%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -14.97, book value per share of Rs 208.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.6x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 20.59x |
| Benchmark Median P/E | 26.6x |
| Benchmark Average P/E | 51.23x |
| Benchmark P/E Range | 0x to 1,378.1x |
| Company P/B Ratio | 0.66x |
| Benchmark Median P/B | 2.79x |
| Company ROE | -10.89% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | -4.85% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 152.28 crore |
| Benchmark Median Market Cap | Rs 789.58 crore |
Natural Capsules Ltd. (NATCAPSUQ) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of 20.59x, which is below the benchmark median of 26.6x, a difference of -22.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Natural Capsules Ltd. (NATCAPSUQ) has a ROE of -10.89%, which is below the benchmark median of 11.22%, a difference of -197.06%. Natural Capsules Ltd. (NATCAPSUQ) has a ROCE of -4.85%, which is below the benchmark median of 13.1%, a difference of -137.02%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| HIMALAYA NUTRAVEDICS INDIA LIM | HNIL | 152.13 | 20.59 | 3.55 | 0 | 0 |
| Gujarat Inject (Kerala) Ltd. | GUJINJEC | 152.5 | 41.77 | 11.03 | 16.61 | 22.93 |
| Medico Remedies Ltd. | MEDICO | 151.45 | 11.11 | 1.89 | 19.02 | 23.28 |
| Kimia Biosciences Ltd. | KIMIABL | 156.13 | 18.24 | 7.63 | 53.7 | 25.24 |
| Auro Laboratories Ltd. | AUROLAB | 147.77 | 28.75 | 3.04 | 7.91 | 9.17 |
Natural Capsules Ltd. (NATCAPSUQ) has a P/E ratio of 20.59x compared with the displayed peer median of 20.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -10.89% compares with a peer median of 16.61% across the companies shown in the table. ROCE stood at -4.85% versus the displayed peer median of 22.93%, providing a capital-efficiency comparison. Natural Capsules Ltd. (NATCAPSUQ) has a market capitalisation of Rs 152.28 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Natural Capsules
- Natural Capsules Share Price is near its 52-week low, which keeps short-term market attention on price action.
- Natural Capsules Share Price Today is below the 50-day moving average of Rs 146.81 and the 200-day moving average of Rs 161.14.
- Natural Capsules Fundamental Analysis shows P/B at 0.66, but ROE at -10.89 and ROCE at -4.85.
- Natural Capsules Stock News also reflects a market-cap profile of Rs 152.28 crore, which places it in a smaller company bracket.
- Healthcare sector comparison shows Natural Capsules trading at lower valuation multiples than the industry median, but with weaker returns.
About Natural Capsules
Natural Capsules Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Based on the available financial snapshot, the company is a small listed healthcare name with a market capitalisation of Rs 152.28 crore. Its latest quarter revenue was Rs 51.15 crore for Sep 2026, which gives some context to Natural Capsules Stock News even though the share price remains under pressure. The company’s current financial profile shows negative earnings per share, negative return ratios and a book value per share of Rs 208.8. That means Natural Capsules Share Price is being judged against a business profile where accounting net worth is higher than the current market price, but operating profitability is not yet supportive. For investors reading Natural Capsules Share Price Today, the business picture is best understood as a value-vs-performance story inside a competitive healthcare and pharma niche.
Track Natural Capsules Share Price on Univest
Use Natural Capsules Ltd. (NATCAPSUQ) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors can track Natural Capsules Share Price on Univest for live price updates, Natural Capsules Technical Analysis, Natural Capsules Fundamental Analysis, shareholding pattern insights and 52-week levels. Univest also helps users monitor Natural Capsules Stock News, valuation ratios, market cap context and sector comparison in one place. That makes it easier to follow Natural Capsules Share Price Today without switching between multiple screens.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Natural Capsules Share Price falling today?
Ans. Natural Capsules Share Price is down 2.97% at Rs 134. The latest Univest data confirms the price move, but it does not establish a company-specific catalyst, so the focus stays on price action and weak momentum.
What is Natural Capsules Share Price today?
Ans. Natural Capsules Share Price Today is Rs 134. It opened at Rs 138.1, matched the previous close at Rs 138.1, and traded between Rs 138.1 and Rs 134 during the latest market update.
Is Natural Capsules near its 52-week low?
Ans. Yes, Natural Capsules Share Price is trading close to its 52-week low and yearly low. That keeps the stock on the radar of traders watching weak price action and support levels in Healthcare.
How does Natural Capsules look on valuation?
Ans. Natural Capsules Share Price trades at a P/E of 20.59 and a P/B of 0.66. That P/B is below the Healthcare industry median of 2.79, but returns remain negative. The company trades at a P/E ratio of 20.59x.
What do ROE and ROCE indicate for Natural Capsules?
Ans. Natural Capsules reports ROE of -10.89% and ROCE of -4.85%. Those figures show weak return generation, so Natural Capsules Share Price is not being supported by current profitability strength. ROE stands at -10.89%.
How does Natural Capsules compare with peers?
Ans. Natural Capsules Share Price sits in a similar market-cap range as its pharma peers, but its return ratios are weaker than several names in the set. Its P/B is also lower than most comparable companies.
What should investors watch next in Natural Capsules Share Price?
Ans. Investors can watch whether Natural Capsules Share Price stays below the 50-day and 200-day moving averages. They may also track any change in earnings quality, book value gap and sector-relative valuation.
Recent Articles

BL Kashyap Share Price Surges 11% to Rs 58.37 on 6.9 Crore Shares Traded: What the Data Shows, and Why No Company Trigger Has Been Found
19 November 2026

Auto Stocks Rally: Nifty Auto Jumps 3.7% as Maruti Surges 6.2% and M&M Adds 3.8%, With Easier Crude and Metal Prices Cited as Drivers
19 November 2026

EPACK Durable (EPACK) Share Price Rises 9.38% as EPACK Durable Share Price Gains in Trade
19 November 2026

AK Capital Services Ltd (AKCAPIT) 52 Week High Streak: 2nd Straight Session Near One-Year Peak
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
BL Kashyap Share Price Surges 11% to Rs 58.37 on 6.9 Crore Shares Traded: What the Data Shows, and Why No Company Trigger Has Been Found
Auto Stocks Rally: Nifty Auto Jumps 3.7% as Maruti Surges 6.2% and M&M Adds 3.8%, With Easier Crude and Metal Prices Cited as Drivers
EPACK Durable (EPACK) Share Price Rises 9.38% as EPACK Durable Share Price Gains in Trade
AK Capital Services Ltd (AKCAPIT) 52 Week High Streak: 2nd Straight Session Near One-Year Peak
Minda Corporation (MINDACORP) Share Price Rises 5.74% Today on Strong Price Action

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





